清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

作者
Jessica L. Mega,Sandra Close,Stephen D. Wiviott,Lei Shen,Richard D. Hockett,John T. Brandt,Joseph R. Walker,Elliott M. Antman,William L. Macias,Eugene Braunwald,Marc S. Sabatine
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:360 (4): 354-362 被引量:2483
标识
DOI:10.1056/nejmoa0809171
摘要

BACKGROUND: Clopidogrel requires transformation into an active metabolite by cytochrome P-450 (CYP) enzymes for its antiplatelet effect. The genes encoding CYP enzymes are polymorphic, with common alleles conferring reduced function. METHODS: We tested the association between functional genetic variants in CYP genes, plasma concentrations of active drug metabolite, and platelet inhibition in response to clopidogrel in 162 healthy subjects. We then examined the association between these genetic variants and cardiovascular outcomes in a separate cohort of 1477 subjects with acute coronary syndromes who were treated with clopidogrel in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction (TRITON-TIMI) 38. RESULTS: In healthy subjects who were treated with clopidogrel, carriers of at least one CYP2C19 reduced-function allele (approximately 30% of the study population) had a relative reduction of 32.4% in plasma exposure to the active metabolite of clopidogrel, as compared with noncarriers (P<0.001). Carriers also had an absolute reduction in maximal platelet aggregation in response to clopidogrel that was 9 percentage points less than that seen in noncarriers (P<0.001). Among clopidogrel-treated subjects in TRITON-TIMI 38, carriers had a relative increase of 53% in the composite primary efficacy outcome of the risk of death from cardiovascular causes, myocardial infarction, or stroke, as compared with noncarriers (12.1% vs. 8.0%; hazard ratio for carriers, 1.53; 95% confidence interval [CI], 1.07 to 2.19; P=0.01) and an increase by a factor of 3 in the risk of stent thrombosis (2.6% vs. 0.8%; hazard ratio, 3.09; 95% CI, 1.19 to 8.00; P=0.02). CONCLUSIONS: Among persons treated with clopidogrel, carriers of a reduced-function CYP2C19 allele had significantly lower levels of the active metabolite of clopidogrel, diminished platelet inhibition, and a higher rate of major adverse cardiovascular events, including stent thrombosis, than did noncarriers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
茶缸子完成签到,获得积分10
8秒前
茶缸子01完成签到,获得积分10
12秒前
16秒前
不以发布了新的文献求助10
24秒前
温柔的海秋完成签到,获得积分10
28秒前
不以完成签到,获得积分10
35秒前
45秒前
1分钟前
顺利的雅旋完成签到,获得积分10
1分钟前
充电宝的应助被科研通管家采纳,获得10
1分钟前
顾矜的应助被科研通管家采纳,获得10
1分钟前
爆米花的应助被科研通管家采纳,获得10
1分钟前
cczzhh发布了新的文献求助10
1分钟前
房天川完成签到 ,获得积分10
1分钟前
qq完成签到 ,获得积分0
1分钟前
eagletyr完成签到 ,获得积分10
1分钟前
成就云朵完成签到,获得积分10
1分钟前
小二郎的应助被钟茵沐采纳,获得10
2分钟前
欣慰怀梦完成签到,获得积分10
2分钟前
2分钟前
小野发布了新的文献求助10
3分钟前
3分钟前
炜大的我的应助被科研通管家采纳,获得10
3分钟前
炜大的我的应助被科研通管家采纳,获得10
3分钟前
liuqingqing发布了新的文献求助10
3分钟前
专注寒蕾完成签到,获得积分10
3分钟前
3分钟前
11发布了新的文献求助10
3分钟前
3分钟前
liuqingqing发布了新的文献求助10
3分钟前
文静飞松完成签到,获得积分10
4分钟前
车厘子完成签到,获得积分10
5分钟前
含蓄的新柔完成签到,获得积分10
5分钟前
虫子完成签到,获得积分10
5分钟前
spinon完成签到,获得积分10
5分钟前
乐乐的应助被虚幻乌冬面采纳,获得10
5分钟前
5分钟前
香蕉觅云的应助被GIA采纳,获得10
5分钟前
披着羊皮的狼完成签到 ,获得积分0
6分钟前
沉默怡完成签到,获得积分10
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195212
求助须知:如何正确求助?哪些是违规求助? 9580926
关于积分的说明 21873010
捐赠科研通 7795208
什么是DOI,文献DOI怎么找? 3437967
关于科研通互助平台的介绍 2561284
邀请新用户注册赠送积分活动 2484694